RCELAVITA Medical, Inc.
$15.52+292% 1Y
$15.52
$3.2752 weeks$15.52
Latest close: a new 52-week highOct 23, 2026what changed →
Is the price fair?
What RCEL's price assumes
AVITA Medical, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 1.68× revenue.
1.68
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 2.15
EV / sales
Details›
- EV / EBIToperating margin −47%: the multiple describes the denominator
- not meaningful
- EV / salesas of 2026-Q2
- 2.15
- Market capitalisation30.9 million shares, counted Aug 3, 2026
- $480M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.